- Home
- ROIV vs HMY Comparison
ROIV vs HMY Comparison
Compare ROIV & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- HMY
- Stock Information
- Founded
- ROIV 2014
- HMY 1950
- Country
- ROIV United Kingdom
- HMY South Africa
- Employees
- ROIV N/A
- HMY N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- HMY Precious Metals
- Sector
- ROIV Health Care
- HMY Basic Materials
- Exchange
- ROIV Nasdaq
- HMY Nasdaq
- Market Cap
- ROIV 8.4B
- HMY 7.5B
- IPO Year
- ROIV N/A
- HMY N/A
- Fundamental
- Price
- ROIV $10.76
- HMY $14.50
- Analyst Decision
- ROIV Buy
- HMY Sell
- Analyst Count
- ROIV 4
- HMY 2
- Target Price
- ROIV $17.50
- HMY $6.60
- AVG Volume (30 Days)
- ROIV 5.8M
- HMY 5.7M
- Earning Date
- ROIV 05-29-2025
- HMY 02-04-2016
- Dividend Yield
- ROIV N/A
- HMY 1.03%
- EPS Growth
- ROIV N/A
- HMY 16.30
- EPS
- ROIV N/A
- HMY 0.88
- Revenue
- ROIV $122,585,000.00
- HMY $3,553,951,394.00
- Revenue This Year
- ROIV N/A
- HMY $23.09
- Revenue Next Year
- ROIV N/A
- HMY $14.74
- P/E Ratio
- ROIV N/A
- HMY $16.04
- Revenue Growth
- ROIV 140.04
- HMY 16.84
- 52 Week Low
- ROIV $8.73
- HMY $7.97
- 52 Week High
- ROIV $13.06
- HMY $18.77
- Technical
- Relative Strength Index (RSI)
- ROIV 49.48
- HMY 45.74
- Support Level
- ROIV $10.58
- HMY $13.62
- Resistance Level
- ROIV $11.77
- HMY $16.54
- Average True Range (ATR)
- ROIV 0.34
- HMY 0.48
- MACD
- ROIV -0.08
- HMY -0.30
- Stochastic Oscillator
- ROIV 15.13
- HMY 30.00
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.